News releases news
Preventing cancer cells from growing by understanding what they 'eat'.
Suzanne Fortier, Principal and Vice-Chancellor of McGill University, extends her congratulations to Mr. Justin Trudeau and the Liberal Party of Canada for the results of the 2015 Canadian federal election.
Discovery advances our understanding of how our brain controls body hydration and temperature
Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from McGill University in Canada.
Emotional abuse may be as harmful as physical abuse and neglect. This finding led by a team of researchers at McGill University complements previous imaging research showing that emotional and physical pain both activate the same parts of the brain.
Discovery of how environmental memories may be transmitted from a man to his grandchildren
A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage.
Transition to parenthood can be a difficult life event. It can have an impact on both parents and on the long-term development of the child. While mother’s "baby blues" have been widely investigated, little research has been conducted on antenatal paternal depression.
It is all about finding the right person. More than 20,000 organ transplants have been performed in Canada over the last 10 years and routinely extend lives. But sometimes the recipient’s immune system recognizes the new organ as foreign and rejects it, which can lead to serious complications.
“This is the first and largest study of the long term safety of medical cannabis use by patients suffering from chronic pain ever conducted,” says lead author, Dr. Ware, pain specialist at the Montreal General Hospital of the MUHC and associate professor in Family Medicine and Anesthesia at McGill University. “We found that medical cannabis, when used by patients who are experienced users, and as part of a monitored treatment program for chronic pain over one year, appears to have a reasonable safety profile.”